Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

Lisa Derosa(Université Paris-Sud), Bertrand Routy(Centre Hospitalier de l’Université de Montréal), Marine Fidelle(Université Paris-Sud), Valerio Iebba(Inserm), Laurie Alla(Université Paris-Saclay), Edoardo Pasolli(University of Naples Federico II), Nicola Segata(University of Trento), Aude Desnoyer(Centre National de la Recherche Scientifique), Filippo Pietrantonio(Fondazione IRCCS Istituto Nazionale dei Tumori), Gladys Ferrere(Inserm), Jean‐Eudes Fahrner(Université Paris-Sud), Emmanuelle Le Chatellier(Université Paris-Saclay), Nicolas Pons(Université Paris-Saclay), Nathalie Galleron(Université Paris-Saclay), Hugo Roume(Université Paris-Saclay), Connie P.M. Duong(Inserm), Laura Mondragón(Université Paris-Sud), Kristina Iribarren(Institut Gustave Roussy), Mélodie Bonvalet(Inserm), Safae Terrisse(Université Paris-Sud), Conrad Rauber(Université Paris-Sud), Anne‐Gaëlle Goubet(Université Paris-Sud), Romain Daillère(Institut Gustave Roussy), Fabien Lemaître(Institut Gustave Roussy), Anna Reni(Inserm), Beatrice Casu(Inserm), Maryam Tidjani Alou(Inserm), Carolina Alves Costa Silva(Inserm), Didier Raoult(Aix-Marseille Université), Karim Fizazi(Institut Gustave Roussy), Bernard Escudier(Institut Gustave Roussy), Guido Kroemer(Karolinska University Hospital), Laurence Albigès(Université Paris-Sud), Laurence Zitvogel(Université Paris-Sud)
European Urology
May 3, 2020
Cited by 374Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis